MHE Week in Review | AIDS 2024

Researchers wanted to provide insight into the relative clinical value of Apretude and lenacapavir compared with no pre-exposure prophylaxis (PrEP), and they presented the data at the International AIDS Society meeting.

A monthly pill would add to the growing number of choices for HIV preexposure prophylaxis, which is now seen as the best hope for curbing the number of new infections.

Integrating people-centered HIV care with primary health care is essential to improving access, equity and health outcomes, but doing so successfully requires coordinated policies, digital transformation, community engagement, and sustained funding, according to experts at IAS 2025.

A separate analysis of the real-world trial found that those who switched from daily antiretroviral treatment to Cabenuva had fewer concerns about treatment.

A larger role for China, perhaps, and the fraught issue of integrating HIV services into services for other diseases.